Fidelity provided a $4.8m second tranche after a first close featuring vehicles for Kyushu University and Osaka University.
J-Pharma, a Japan-based cancer therapy developer, has increased a series D round that included Kyushu University’s QB Capital unit and Osaka University-affiliated Osaka University Venture Capital.
The second tranche of the round involved ¥500m ($4.8m) from Eight Roads Ventures and F-Prime Capital Partners, two venture capital vehicles for investment and financial services group Fidelity.
The first close in July 2020 included the aforementioned university vehicles as well as contract manufacturing firm KNC, chemicals trading firm Kisco and…
